Eyenovia Statistics
Total Valuation
Eyenovia has a market cap or net worth of $30.98 million. The enterprise value is $35.65 million.
| Market Cap | 30.98M |
| Enterprise Value | 35.65M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Eyenovia has 50.61 million shares outstanding. The number of shares has increased by 21.94% in one year.
| Shares Outstanding | 50.61M |
| Shares Change (YoY) | +21.94% |
| Shares Change (QoQ) | +20.69% |
| Owned by Insiders (%) | 16.20% |
| Owned by Institutions (%) | 22.48% |
| Float | 36.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9,087.63 |
| Forward PS | 7.11 |
| PB Ratio | 3.82 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9,412.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 1.79.
| Current Ratio | 2.17 |
| Quick Ratio | 1.57 |
| Debt / Equity | 1.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.49 |
Financial Efficiency
Return on equity (ROE) is -213.30% and return on invested capital (ROIC) is -101.27%.
| Return on Equity (ROE) | -213.30% |
| Return on Assets (ROA) | -89.20% |
| Return on Capital (ROIC) | -101.27% |
| Revenue Per Employee | $66 |
| Profits Per Employee | -$478,265 |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.47% in the last 52 weeks. The beta is 1.66, so Eyenovia's price volatility has been higher than the market average.
| Beta (1Y) | 1.66 |
| 52-Week Price Change | -86.47% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 37.65 |
| Average Volume (30 Days) | 1,279,296 |
Short Selling Information
The latest short interest is 5.38 million, so 10.63% of the outstanding shares have been sold short.
| Short Interest | 5.38M |
| Short Previous Month | 5.22M |
| Short % of Shares Out | 10.63% |
| Short % of Float | 14.72% |
| Short Ratio (days to cover) | 3.19 |
Income Statement
In the last 12 months, Eyenovia had revenue of $3,787 and -$27.26 million in losses. Loss per share was -$0.66.
| Revenue | 3,787 |
| Gross Profit | 7,574 |
| Operating Income | -25.40M |
| Pretax Income | -27.26M |
| Net Income | -27.26M |
| EBITDA | -24.11M |
| EBIT | -24.89M |
| Loss Per Share | -$0.66 |
Balance Sheet
The company has $14.85 million in cash and $16.08 million in debt, giving a net cash position of -$1.23 million or -$0.02 per share.
| Cash & Cash Equivalents | 14.85M |
| Total Debt | 16.08M |
| Net Cash | -1.23M |
| Net Cash Per Share | -$0.02 |
| Equity / Book Value | 9.00M |
| Book Value Per Share | 0.18 |
| Working Capital | 11.18M |
Cash Flow
In the last 12 months, operating cash flow was -$23.84 million and capital expenditures -$3.97 million, giving a free cash flow of -$27.81 million.
| Operating Cash Flow | -23.84M |
| Capital Expenditures | -3.97M |
| Free Cash Flow | -27.81M |
| FCF Per Share | -$0.68 |
Margins
Gross margin is 200.00%, with operating and profit margins of -670,685.82% and -719,859.94%.
| Gross Margin | 200.00% |
| Operating Margin | -670,685.82% |
| Pretax Margin | -719,859.94% |
| Profit Margin | -719,859.94% |
| EBITDA Margin | -636,547.06% |
| EBIT Margin | -657,228.55% |
| FCF Margin | -734,277.16% |
Dividends & Yields
Eyenovia does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.94% |
| Shareholder Yield | -21.94% |
| Earnings Yield | -79.21% |
| FCF Yield | -80.80% |
Analyst Forecast
The average price target for Eyenovia is $10.00, which is 1,549.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 1,549.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 720.21% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Eyenovia has an Altman Z-Score of -8.42 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.42 |
| Piotroski F-Score | 1 |